FDA commissioner with experience akin to drug advisory cmte. chair suggested by NDMA.
This article was originally published in The Tan Sheet
Executive Summary
FDA COMMISSIONER SEARCH: DRUG ADVISORY CMTE. CHAIR EXPERIENCE cited by the Nonprescription Drug Manufacturers Association as a desirable qualification for the future FDA head. In a Feb. 4 letter to HHS Secretary Donna Shalala, NDMA recommends that the new commissioner have "a recognized expertise in managing sensitive medical and scientific issues, as might be found in a person who had served as chairman to a drug advisory committee." Among the names that have been circulated as a possible successor to retiring FDA Commissioner David Kessler, MD, is former Nonprescription Drugs Advisory Committee Chair Randy Juhl, PhD, dean of the University of Pittsburgh School of Pharmacy ("The Tan Sheet" Dec. 9, 1996, p. 11).